Tony Culyer
Internal Affiliate

Profile

Biography

Tony has been at York since 1969 where his main roles have been as Assistant Director of the (then) Institute for Social & Economic Research, Head of the Department of Economics & Related Studies, and Pro-Vice-Chancellor and Deputy Vice-Chancellor of the University. He currently holds a part-time chair in Economics at York and is Ontario Research Chair in Health Policy and System Design at the University of Toronto. He was the founding Vice Chair of the National Institute for Health & Clinical Excellence and is a member of the NICE Citizens Council Committee and the NICE International Advisory Committee. He chairs the Policy and Editorial Committees of the Office of Health Economics and until 2010 he also chaired the Research Advisory Council of the Workplace Safety & Insurance Board in Ontario. He is a founding editor of the Journal of Health Economics, a Founding Fellow of the Academy of Medical Sciences, an Honorary Fellow of the Royal College of Physicians, a CBE and has an honorary doctorate from the Stockholm School of Economics.

His current research interests relate to problems in thinking about how equity in health is best achieved and how decisions about cost-effective technologies are best arrived at.

Research

Overview

  • Tony's current research interests relate to problems in thinking about how equity in health is best achieved and how decisions about cost-effective technologies are best arrived at.

Publications

Full publications list

2013

  • Shah K, Cookson R, Culyer AJ, Littlejohns P. NICE’s social value judgements about equity in health and health care. Health Economics, Policy and Law 2012;8(2):145-65. Download from Cambridge journals

2012

  • Cookson R, Claxton K. The humble economist. Tony Culyer on health, health care and social decision making. Office of Health Economics, London and University of York, 2012. The humble economist 
  • Culyer AJ. Hic sunt dracones: the future of Health Technology Assessment - one economist's perspective. Medical Decision Making 2012;32:E25-E32.
  • Culyer AJ, Bombard Y. An equity framework for health technology assessments. Medical Decision Making 2012;32(3):428-441.
  • Wagstaff A, Culyer AJ. Four decades of Health Economics through a bibliometric lens. Journal of Health Economics 2012;31:406-39. 

2011

  • Chase R, Culyer AJ, Dobrow M, Coyte P, Sawka C, O'Reilly S, Laing K, Trudeau M, Smith S, Hoch J, Morgan S, Peacok S, Abbott R, Sullivan T. Access to cancer drugs in Canada: looking beyond coverage decisions. Healthcare Policy 2011;6:27-35.
  • Claxton K, Paulden M, Gravelle H, Brouwer W, Culyer AJ. Discounting and decision making in the economic evaluation of health care technologies. Health Economics 2011;20:2-15. Download from Wiley interscience  
  • Culyer AJ. Maximising the odds. New Statesman (supplement: Competition in a New Society: National Health) 2011;15 December 6-8.
  • Culyer AJ. UK report: NHS 'reforms: Health Care Cost Monitor 1-2, The Hastings Center; 2011. Download from the Hastings Center 
  • Culyer AJ, Bombard Y. An equity checklist: a framework for health technology assessments. Centre for Health Economics, University of York; CHE Research Paper 62 (PDF  , 213kb)‌‎ , 2011.
  • Shah K, Cookson R, Culyer AJ, Littlejohns P. Nice's social value judgements about equity in health and health care. Centre for Health Economics, University of York; CHE Research Paper 70 (PDF  , 419kb)‌‎ ,2011.
  • Tso P, Culyer AJ, Brouwers M, Dobrow MJ. Developing a decision aid to guide public sector health policy decisions: A study protocol. Implementation Science 2011;6(46).
  • Wagstaff A, Culyer AJ. Four decades of Health Economics through a bibliometric lens. World Bank Policy Research Working Paper Series 2011;5829.

2010

  • Cookson R, Culyer AJ.  Measuring overall population health - the use and abuse of QALYs, in Killoran A, Kelly M (eds). Evidence based public health: effectiveness and efficiency, Oxford: Oxford University Press, 2010, 148-168.
  • Culyer AJ. The dictionary of health economics. 2nd Edition, Cheltenham: Edward Elgar, 2010.
  • Culyer AJ. Perspective and desire in comparative effectiveness research - the relative unimportance of mere preferences, the central importance of context. Pharmacoeconomics 2010;28:889-97.
  • Paulden M, Culyer AJ. Does cost-effectiveness analysis discriminate against patients with short life expectancy? Matters of logic and matters of context. Centre for Health Economics, University of York; CHE Research Paper 55 (PDF  , 452kb)‌‎ 2010.

2009

  • Chalkidou K, Culyer AJ, Naidoo B, Littlejohns P. The challenges of developing cost-effective public health guidance: a NICE perspective. In: Dawson S, Morris ZS, editors. Future public health: burdens, challenges and opportunities. Basingstoke: Palgrave Macmillan; 2009. p. 276-91.
  • Culyer AJ. Health, distribution and fairness - sorting out the theory and matching it to future policy practice (notes for the Select Committee on Health) House of Commons Select Committee on Health, 3 rd Report: Health Inequalities; 2009.
  • Culyer AJ. Deliberative processes in decisions about health care technologies: combining different types of evidence, values, algorithms and people. London: Office of Health Economics; 2009.
  • Culyer AJ. How nice is NICE? A conversation with Anthony Culyer ,Health Care Cost Monitor, 2009 Hastings Centre Blog.
  • Dobrow MJ, Chafe R, Burchett HED, Culyer AJ, Lemieux-Charles L. Designing deliberative methods for combining heterogeneous evidence: A systematic review and qualitative scan. A report to the Canadian Health Services Research Foundation. Ottawa; 2009.

2008

  • Brouwer WBF, Culyer AJ, Job N, van Exel A, Rutten FFH. Welfarism vs. extra-welfarism. Journal of Health Economics. 2008;27:325-38.
  • Chalkidou K, Culyer AJ, Littlejohns P, Doyle P, Hoy A. Imbalances in funding for clinical and public health research in the UK: can NICE research recommendations make a difference? Evidence and Policy. 2008;4:355-69.
  • Chalkidou K, Culyer AJ, Naidoo B, Littlejohns P. Cost-effective public health guidance: asking questions from the decision-maker's viewpoint. Health Economics. 2008;17:441-8.
  • Chalkidou K, Walley T, Culyer AJ, Littlejohns P, Hoy A. Evidence-informed evidence making. Journal of Health Services Research and Policy. 2008;13:167-73.
  • Claxton K, Briggs A, Buxton M, Culyer A, McCabe C, Walker S, Sculpher M. Value based pricing for NHS drugs: an opportunity not to be missed? BMJ. 2008;336:251-4.  Download from BMJ 
  • Claxton K, Culyer A. Not a NICE fallacy: A reply to Dr Quigley. Journal of Medical Ethics. 2008;34:598-601.  
  • Culyer AJ, Amick B, LaPorte A. What is a little more health and safety worth? In: Tompa E, Culyer AJ, Dolinschi R, eds. Economic evaluation of interventions for occupational health and safety: developing good practice. Oxford: Oxford University Press 2008:15-35.
  • Culyer AJ, Sculpher M. Lessons from health technology assessment. In: Tompa E, Culyer A, Dolinschi R, eds. Economic evaluation of interventions for occupational health and safety: developing good practice. Oxford: Oxford University Press 2008:51-69.
  • Culyer AJ, Tompa E. Equity. In: Tompa E, Culyer AJ, Dolinschi R, eds. Economic evaluation of interventions for occupational health and safety: developing good practice. Oxford: Oxford University Press 2008:215-31.
  • Hurley J, Pasic D, Lavis J, Culyer AJ, Mustard C, Gnam W. Parallel payers and preferred access: how Canada's workers' compensation boards expedite care for injured and ill workers. HealthcarePapers. 2008;8:6-14.
  • Hurley J, Culyer AJ, Gnam W, Lavis J, Mustard C, Pasic D. Response to commentaries. HealthcarePapers. 2008;8:52-4.
  • Hurley J, Pasic D, Lavis J, Mustard C, Culyer AJ, Gnam W. Parallel lines do intersect: interactions between the workers' compensation and provincial publicly financed health care systems in Canada. Health Care Policy. 2008;3:100-12.
  • McCabe C, Culyer AJ, Claxton K. The NICE cost-effectiveness threshold: what it is and what it means. Pharmacoeconomics. 2008;26(9):733-44.
  • Tompa E, Culyer AJ, Dolinschi R. Suggestions for a reference case. In: Tompa E, Culyer AJ, Dolinschi R, eds. Economic evaluation of interventions for occupational health and safety: developing good practice. Oxford: Oxford University Press 2008:235-44.
  • Tompa E, Culyer AJ, Dolinschi R, (Eds). Economic evaluation of interventions for occupational health and safety: developing good practice. Oxford: Oxford University Press 2008.

2007 

  • Claxton K, Culyer A. Rights, responsibilities and NICE: a rejoinder to Harris. Journal of Medical Ethics. 2007;33:462-4.
  • Claxton K, Sculpher M, Culyer A. Mark versus Luke? Appropriate methods for the evaluation of public health interventions. Centre for Health Economics, University of York; CHE Research Paper 31 (PDF  , 204kb)‌‎ , 2007.
  • Culyer AJ. NICE misconceptions. The Lancet. September 11 2007.
  • Culyer AJ. Equity of what in health care? Why the traditional answers don't help policy - and what to do in the future. HealthcarePapers. 2007;8(Sp):12-26.
  • Culyer AJ. Need - an instrumental view. In: Ashcroft R, Dawson A, Draper H, McMillan J, editors. Principles of health care ethics, 2nd Edition. Chichester:Wiley;2007;231-238.
  • Culyer AJ. When and how cancer chemotherapy should be privately funded. Oncology Exchange, 2007;6:47.
  • Culyer AJ. Merit goods and the welfare economics of coercion. In: Ver Eecke W,  editor. Anthology regarding nmerit goods. The unfinished ethical revolution in economic theory. West Lafayette: Purdue University Press;2007;174-200 (reprinted from Public Finance. 1971;26:546-572).
  • Culyer AJ, McCabe C, Briggs A, Claxton K, Buxton M, Akehurst R, Sculpher M, Brazier J. Searching for a threshold, not setting one: the role of the National Institute for Health and Clinical Excellence. Journal of Health Services Research and Policy. 2007;12:56-8.
  • Culyer AJ, McCabe C, Briggs A, Claxton K, Buxton M, Akehurst R, Sculpher M, Brazier J. Not so… Journal of Health Service Research and Policy. 2007;12:190-191. (letter: reply to G Mooney, J Coast, S Jan, D McIntyre, M Ryan and V Wiseman).
  • Culyer AJ. Resource allocation in health care: Alan Williams’ decision maker, the authority and Pareto. In: Mason A, Towse A, editors. The Ideas and Influence of Alan Williams: Be Reasonable -Do it My Way! . Oxford: Radcliffe Publishing; 2007. p. 57-74.
  • Robson LS, Clarke J, Cullen K, Bielecky A, Severin C, Bigelow P, Irvin E, Culyer AJ,  Mahood Q. The effectiveness of occupational health and safety management system interventions: A systematic review. Safety Science. 2007;45:329-53.

2006

  • Weighing up the evidence: making evidence-informed guidance accurate, achievable, and acceptable, (Culyer AJ  Convenor with Jonathan Lomas) 2006, Ottawa: Canadian Health Services Research Foundation,14 pp.
  • Review of Citizens’ Councils and Recommendations for the Creation of a Citizens’ Council in Ontario as Mandated under the Transparent Drug System for Patients Act, University of Toronto Priority Setting in Health Care Research Group (Culyer AJ  with Andreas Laupacis, Doug Martin, Alan Hudson, Wendy Levinson, Terrence Sullivan,  Bill Evans, Steven Pearson, Irfan Dhalla, Tasha Jeyanathan) 2006.
  • Claxton K, Culyer AJ, Sculpher M, McCabe C, Briggs A, Akehurst R, Brazier J, Buxton M. Discounting and cost-effectiveness in NICE - stepping back to sort out a confusion (Editorial). Health Economics 2006;15:1-4.
  • Claxton K, Culyer AJ. Wickedness or folly? The ethics of NICE’s decisions. Journal of Medical Ethics 2006;32: 373-377.
  • Culyer AJ. NICE's use of cost-effectiveness as an exemplar of a deliberative process. Health Economics, Policy and Law. 2006;1:299-318.
  • Culyer AJ. Paying for performance: neither the end of the beginning nor the beginning of the end. HealthcarePapers. 2006;6:34-8.
  • Culyer AJ. Editor.  Health economics: critical perspectives on the world economy, 4 Vols., Abingdon:Routledge, 2006 (Vol. 1, pp. xxvi + 545; Vol. 2, pp,. xi + 450; Vol. 3, pp. viii + 386; Vol. 4, pp. xi + 600).
  • Culyer AJ. Evidence, economics and values in coverage decisions. In Morgan S. Editor. Toward a national pharmaceuticals strategy. Vancouver: Centre for Health Services and Policy Research UBC. 2006;10-11.
  • Culyer AJ. The bogus conflict between efficiency and equity. Health Economics. 2006; 15:1155-1158(Editorial).
  • Culyer AJ. Welfarism vs.Extra-Welfarism. Köz-Gazdaság Tudományos Füzetek (Public Economics Science Journal) 2006;1:89-101.
  • Culyer AJ. The nature of the commodity 'health care' and its efficient allocation. In Culyer AJ. Editor.  Health economics: critical perspectives on the world economy, London: Routledge. 2006; 324-346 (reprinted from Oxford Economic Papers, 1971;23: 189-211).
  • Culyer AJ. The normative economics of health care finance and provision. In: Culyer AJ.  Editor. Health economics: critical perspectives on the world economy, London: Routledge, 2006;347-384. (reprinted from A. McGuire, P. Fenn and K. Mayhew (eds.) Providing health care: the economics of alternative systems of finance and delivery, Oxford: Oxford University Press. 1991;34-58).
  • Culyer AJ, Evans RG. Mark Pauly on welfare economics: normative rabbits from positive hats. In: Culyer AJ.  Editor. Health economics: critical perspectives on the world economy, London: Routledge. 2006;148-157 (reprinted from Journal of Health Economics. 1996;15: 243-251).
  • Culyer AJ, Lomas J. Deliberative processes and evidence-informed decision-making in health care – do they work and how might we know?  Evidence and Policy. 2006;2: 357-371.
  • Culyer AJ, Saltman R. Privatization – assessing strategies in a central Asian republic. In: Zöllner H, Stoddart G, Selby Smith V. editors Learning to live with health economics, Copenhagen: WHO. 2006; III-95 - III-105 (copyrighted 2003, published 2006).
  • Culyer AJ, Wagstaff A. Equity and equality in health and health care. In: Culyer AJ  Editor: Health economics: critical perspectives on the world economy, London: Routledge. 2006;483-509. (reprinted from Journal of Health Economics. 1993;12:431-457).
  • Szende A, Culyer AJ.  The inequity of informal payments for health care: the case of Hungary. Health Policy. 2006;75:262-271.

2005

  • Anderson GM, Bronskill S, Mustard CA, Culyer AJ, Alter DA, Manuel DG. Both clinical epidemiology and population health perspectives can define the role of health care in reducing health disparities. Journal of Clinical Epidemiology 2005;58:757-62.
  • Culyer AJ. The dictionary of health economics. Cheltenham: Edward Elgar, 2005.
  • Culyer AJ. Involving stakeholders in healthcare decisions - the experience of the National Institute for Health and Clinical Excellence (NICE) in England and Wales. Healthcare Quarterly 2005;8:56-60.
  • Culyer AJ. Egészség-gazdaságtan, egészségügyi közgazdászok, és az egészségpolitikai döntéshozás politikája (Health economics, health economists and the politics of policy making). In: Gulácsi L, editor. Egészég-Gazdaságtan. Budapest: Medicina Könyvkiadó Rt; 2005. p. 35-44.
  • Godfrey C, Parrott S, Eaton G, Culyer A, McDougall C. Can we model the impact of increased treatment expenditure on the UK drug market. In: Lindgren B, Grossman M, editors. Substance use: individual behaviour, social interactions, markets and politics. Advances in health economics and health services research. Volume 16. New York: Elsevier; 2005. p. 265-84.
  • Lomas J, Culyer AJ, McCutcheon C, McAuley L, Law S. Conceptualizing and combining evidence for health system guidance. Ottawa: Canadian Health Services Research Foundation; 2005.
  • Robson L, Clarke J, Cullen K, Bielecky A, Severin C, Bigelow P, Irvine E, Culyer AJ, Mahood Q. The effectiveness of occupational health and safety management systems: a systematic review (full report). Toronto: Institute for Work & Health; 2005.
  • Robson L, Clarke J, Cullen K, Bielecky A, Severin C, Bigelow P, Irvine E, Culyer AJ, Mahood Q. The effectiveness of occupational health and safety management systems: a systematic review (summary). Toronto: Institute for Work & Health; 2005.
Staff photo of Tony Culyer

Contact details

Tony Culyer
Internal Affiliate
Centre for Health Economics